PharmChem Valuation
| PCHM Stock | USD 3.10 0.00 0.00% |
At this time, the company appears to be overvalued. PharmChem holds a recent Real Value of $2.73 per share. The prevailing price of the company is $3.1. Our model determines the value of PharmChem from analyzing the company fundamentals such as Price To Earning of (2.30) X, return on equity of -0.24, and Operating Margin of (0.06) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PharmChem's price fluctuation is risky at this time. Calculation of the real value of PharmChem is based on 3 months time horizon. Increasing PharmChem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PharmChem pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PharmChem. Since PharmChem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PharmChem Pink Sheet. However, PharmChem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.1 | Real 2.73 | Hype 3.1 | Naive 3.24 |
The intrinsic value of PharmChem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PharmChem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PharmChem helps investors to forecast how PharmChem pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PharmChem more accurately as focusing exclusively on PharmChem's fundamentals will not take into account other important factors: PharmChem Total Value Analysis
PharmChem is at this time forecasted to have valuation of 17.56 K with market capitalization of 17.55 K, debt of 0, and cash on hands of 626 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PharmChem fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.56 K | 17.55 K | 0 | 626 K |
PharmChem Investor Information
The company has price-to-book ratio of 0.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PharmChem recorded a loss per share of 0.35. The entity last dividend was issued on the 7th of February 2023. The firm had 1:6 split on the 5th of November 2020. Based on the analysis of PharmChem's profitability, liquidity, and operating efficiency, PharmChem is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.PharmChem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PharmChem has an asset utilization ratio of 158.77 percent. This suggests that the Company is making $1.59 for each dollar of assets. An increasing asset utilization means that PharmChem is more efficient with each dollar of assets it utilizes for everyday operations.PharmChem Profitability Analysis
The company reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M.About PharmChem Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of PharmChem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PharmChem based exclusively on its fundamental and basic technical indicators. By analyzing PharmChem's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of PharmChem's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of PharmChem. We calculate exposure to PharmChem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PharmChem's related companies.PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.
8 Steps to conduct PharmChem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PharmChem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PharmChem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PharmChem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PharmChem's revenue streams: Identify PharmChem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PharmChem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PharmChem's growth potential: Evaluate PharmChem's management, business model, and growth potential.
- Determine PharmChem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PharmChem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PharmChem Growth Indicators
Investing in growth stocks can be very risky. If the company such as PharmChem does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Forward Annual Dividend Rate | 0.12 |
Other Information on Investing in PharmChem Pink Sheet
PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.